ADVERTISEMENT

Sensex, Nifty Gain For The Third Consecutive Day After Session Of Milestones

Catch all live updates on share prices, index moves, corporate announcements and more from Indian stock markets today.

<div class="paragraphs"><p>Computer keyboards and screens used for trading on the financial markets are seen on a trader’s desk. (Photographer: Chris Ratcliffe/Bloomberg)</p></div>
Computer keyboards and screens used for trading on the financial markets are seen on a trader’s desk. (Photographer: Chris Ratcliffe/Bloomberg)
LIVE FEED
Latest First
  • Oldest First

Closing Bell

India’s equity benchmarks close higher for the third consecutive session marked by milestones, in which both the NSE Nifty 50 and S&P BSE Sensex hit record highs in intraday trade. Gains in power, auto, banking and utility stocks aided the advance.

The S&P BSE Sensex index rose 0.13% to 60,135.78. The 30-stock index hit a record 60,476.13 in intraday trade. The NSE Nifty 50 Index crossed 18,000 mark for the first time in intraday trade, before closing with gains of 0.28% at 17,945.95, a record close for the index. The 50-stock gauge hit a record 18,041.95 in intraday trade. HDFC Bank Ltd. contributed the most to the index gain, increasing 1.9%. Tata Motors Ltd. had the largest increase, rising 8.6%. Today, 33 of 50 shares rose, while 17 fell.

Sensex, Nifty Gain For The Third Consecutive Day After Session Of Milestones

The broader indices almost mirrored their larger peers, with both S&P BSE MidCap S&P BSE SmallCap gaining over 0.5%. Fifteen of the 19 sectoral indexes compiled by BSE Ltd. advanced, with the S&P BSE Utilities, S&P BSE Power and S&P BSE Auto indexes index gaining over 2.5%. On the flipside, S&P BSE Information Technology index shed nearly 3%

The market breadth was skewed in favour of bulls. About 1,958 stocks advanced, 1,473 declined and 161 remained unchanged.

ADVERTISEMENT

Alembic Pharma Jumps As EIR From USFDA For Its Karakhadi New Injectable Facility

Shares of Alembic Pharmaceuticals Ltd. climbed over 5.51% to Rs 819.8 apiece after the company received Establishment Inspection Report for its new injectable facility at Karakhadi from the U.S. Food and Drug Administration. The USFDA had carried out the inspection at the new facilities between January 28 and February 6, 2021.

In an exchange filing, Alembic Pharma said that the U.S. FDA found the company's responses to their observations adequate. Compliance verifications would be performed by U.S. FDA during reinspection of the facility in the next review cycle.


Utilities Stocks Advance; Tata Power, Torrent Power Rise

Sensex, Nifty Gain For The Third Consecutive Day After Session Of Milestones
ADVERTISEMENT

Power Stocks Advance; Indian Energy Exchange Shares Up 11%

Sensex, Nifty Gain For The Third Consecutive Day After Session Of Milestones

Ramkrishna Forgings Reports Sequential Growth In Revenue & PAT In September Quarter

Ramkrishna Forgings Ltd. reported sequential growth in revenue and net profit in its September quarter numbers

Q2 Results (Standalone)

  • Revenue at Rs 578.94 crore vs Rs 417.14 crore QoQ

  • Net profit at Rs 50.11 crore vs Rs 24.61 crore QoQ

  • EBITDA at Rs 139.18 crore vs Rs 95.32 crore QoQ

  • Quarterly EPS for Q2FY22 is Rs 15.68 per share.

  • Declared second interim dividend of Rs 0.50 per share.

Source: Exchange Filing.

ADVERTISEMENT